Pharma & Healthcare
Global Multiple Myeloma Therapy Market Research Report 2025
- Jul 24, 25
- ID: 404656
- Pages: 72
- Figures: 80
- Views: 4
The global market for Multiple Myeloma Therapy was valued at US$ 24290 million in the year 2024 and is projected to reach a revised size of US$ 37030 million by 2031, growing at a CAGR of 6.3% during the forecast period.
Multiple myeloma or plasma cell myeloma is a form of cancer of the plasma cells. In this condition, the body produces abnormal plasma cells which collect near the bone marrow and hamper normal functioning of the healthy plasma cells.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Multiple Myeloma Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multiple Myeloma Therapy.
The Multiple Myeloma Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Multiple Myeloma Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Multiple Myeloma Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Celgene
Johnson & Johnson
GlaxoSmithKline plc
Roche
AbbVie Inc.
Amgen Inc.
Novartis AG
Millennium Pharmaceuticals
Innate Pharma SA
Segment by Type
Targeted Therapy
Chemotherapy
Radiotherapy
Bone Marrow Transplant
Others
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Multiple Myeloma Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Multiple myeloma or plasma cell myeloma is a form of cancer of the plasma cells. In this condition, the body produces abnormal plasma cells which collect near the bone marrow and hamper normal functioning of the healthy plasma cells.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Multiple Myeloma Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multiple Myeloma Therapy.
The Multiple Myeloma Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Multiple Myeloma Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Multiple Myeloma Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Celgene
Johnson & Johnson
GlaxoSmithKline plc
Roche
AbbVie Inc.
Amgen Inc.
Novartis AG
Millennium Pharmaceuticals
Innate Pharma SA
Segment by Type
Targeted Therapy
Chemotherapy
Radiotherapy
Bone Marrow Transplant
Others
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Multiple Myeloma Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiple Myeloma Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Targeted Therapy
1.2.3 Chemotherapy
1.2.4 Radiotherapy
1.2.5 Bone Marrow Transplant
1.2.6 Others
1.3 Market by Application
1.3.1 Global Multiple Myeloma Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Multiple Myeloma Therapy Market Perspective (2020-2031)
2.2 Global Multiple Myeloma Therapy Growth Trends by Region
2.2.1 Global Multiple Myeloma Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Multiple Myeloma Therapy Historic Market Size by Region (2020-2025)
2.2.3 Multiple Myeloma Therapy Forecasted Market Size by Region (2026-2031)
2.3 Multiple Myeloma Therapy Market Dynamics
2.3.1 Multiple Myeloma Therapy Industry Trends
2.3.2 Multiple Myeloma Therapy Market Drivers
2.3.3 Multiple Myeloma Therapy Market Challenges
2.3.4 Multiple Myeloma Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Multiple Myeloma Therapy Players by Revenue
3.1.1 Global Top Multiple Myeloma Therapy Players by Revenue (2020-2025)
3.1.2 Global Multiple Myeloma Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Multiple Myeloma Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Multiple Myeloma Therapy Revenue
3.4 Global Multiple Myeloma Therapy Market Concentration Ratio
3.4.1 Global Multiple Myeloma Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiple Myeloma Therapy Revenue in 2024
3.5 Global Key Players of Multiple Myeloma Therapy Head office and Area Served
3.6 Global Key Players of Multiple Myeloma Therapy, Product and Application
3.7 Global Key Players of Multiple Myeloma Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Multiple Myeloma Therapy Breakdown Data by Type
4.1 Global Multiple Myeloma Therapy Historic Market Size by Type (2020-2025)
4.2 Global Multiple Myeloma Therapy Forecasted Market Size by Type (2026-2031)
5 Multiple Myeloma Therapy Breakdown Data by Application
5.1 Global Multiple Myeloma Therapy Historic Market Size by Application (2020-2025)
5.2 Global Multiple Myeloma Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Multiple Myeloma Therapy Market Size (2020-2031)
6.2 North America Multiple Myeloma Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Multiple Myeloma Therapy Market Size by Country (2020-2025)
6.4 North America Multiple Myeloma Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Multiple Myeloma Therapy Market Size (2020-2031)
7.2 Europe Multiple Myeloma Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Multiple Myeloma Therapy Market Size by Country (2020-2025)
7.4 Europe Multiple Myeloma Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Multiple Myeloma Therapy Market Size (2020-2031)
8.2 Asia-Pacific Multiple Myeloma Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Multiple Myeloma Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Multiple Myeloma Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Multiple Myeloma Therapy Market Size (2020-2031)
9.2 Latin America Multiple Myeloma Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Multiple Myeloma Therapy Market Size by Country (2020-2025)
9.4 Latin America Multiple Myeloma Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Multiple Myeloma Therapy Market Size (2020-2031)
10.2 Middle East & Africa Multiple Myeloma Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Multiple Myeloma Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Multiple Myeloma Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Multiple Myeloma Therapy Introduction
11.1.4 Sanofi Revenue in Multiple Myeloma Therapy Business (2020-2025)
11.1.5 Sanofi Recent Development
11.2 Celgene
11.2.1 Celgene Company Details
11.2.2 Celgene Business Overview
11.2.3 Celgene Multiple Myeloma Therapy Introduction
11.2.4 Celgene Revenue in Multiple Myeloma Therapy Business (2020-2025)
11.2.5 Celgene Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Multiple Myeloma Therapy Introduction
11.3.4 Johnson & Johnson Revenue in Multiple Myeloma Therapy Business (2020-2025)
11.3.5 Johnson & Johnson Recent Development
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Company Details
11.4.2 GlaxoSmithKline plc Business Overview
11.4.3 GlaxoSmithKline plc Multiple Myeloma Therapy Introduction
11.4.4 GlaxoSmithKline plc Revenue in Multiple Myeloma Therapy Business (2020-2025)
11.4.5 GlaxoSmithKline plc Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Multiple Myeloma Therapy Introduction
11.5.4 Roche Revenue in Multiple Myeloma Therapy Business (2020-2025)
11.5.5 Roche Recent Development
11.6 AbbVie Inc.
11.6.1 AbbVie Inc. Company Details
11.6.2 AbbVie Inc. Business Overview
11.6.3 AbbVie Inc. Multiple Myeloma Therapy Introduction
11.6.4 AbbVie Inc. Revenue in Multiple Myeloma Therapy Business (2020-2025)
11.6.5 AbbVie Inc. Recent Development
11.7 Amgen Inc.
11.7.1 Amgen Inc. Company Details
11.7.2 Amgen Inc. Business Overview
11.7.3 Amgen Inc. Multiple Myeloma Therapy Introduction
11.7.4 Amgen Inc. Revenue in Multiple Myeloma Therapy Business (2020-2025)
11.7.5 Amgen Inc. Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Details
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Multiple Myeloma Therapy Introduction
11.8.4 Novartis AG Revenue in Multiple Myeloma Therapy Business (2020-2025)
11.8.5 Novartis AG Recent Development
11.9 Millennium Pharmaceuticals
11.9.1 Millennium Pharmaceuticals Company Details
11.9.2 Millennium Pharmaceuticals Business Overview
11.9.3 Millennium Pharmaceuticals Multiple Myeloma Therapy Introduction
11.9.4 Millennium Pharmaceuticals Revenue in Multiple Myeloma Therapy Business (2020-2025)
11.9.5 Millennium Pharmaceuticals Recent Development
11.10 Innate Pharma SA
11.10.1 Innate Pharma SA Company Details
11.10.2 Innate Pharma SA Business Overview
11.10.3 Innate Pharma SA Multiple Myeloma Therapy Introduction
11.10.4 Innate Pharma SA Revenue in Multiple Myeloma Therapy Business (2020-2025)
11.10.5 Innate Pharma SA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiple Myeloma Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Targeted Therapy
1.2.3 Chemotherapy
1.2.4 Radiotherapy
1.2.5 Bone Marrow Transplant
1.2.6 Others
1.3 Market by Application
1.3.1 Global Multiple Myeloma Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Multiple Myeloma Therapy Market Perspective (2020-2031)
2.2 Global Multiple Myeloma Therapy Growth Trends by Region
2.2.1 Global Multiple Myeloma Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Multiple Myeloma Therapy Historic Market Size by Region (2020-2025)
2.2.3 Multiple Myeloma Therapy Forecasted Market Size by Region (2026-2031)
2.3 Multiple Myeloma Therapy Market Dynamics
2.3.1 Multiple Myeloma Therapy Industry Trends
2.3.2 Multiple Myeloma Therapy Market Drivers
2.3.3 Multiple Myeloma Therapy Market Challenges
2.3.4 Multiple Myeloma Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Multiple Myeloma Therapy Players by Revenue
3.1.1 Global Top Multiple Myeloma Therapy Players by Revenue (2020-2025)
3.1.2 Global Multiple Myeloma Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Multiple Myeloma Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Multiple Myeloma Therapy Revenue
3.4 Global Multiple Myeloma Therapy Market Concentration Ratio
3.4.1 Global Multiple Myeloma Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiple Myeloma Therapy Revenue in 2024
3.5 Global Key Players of Multiple Myeloma Therapy Head office and Area Served
3.6 Global Key Players of Multiple Myeloma Therapy, Product and Application
3.7 Global Key Players of Multiple Myeloma Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Multiple Myeloma Therapy Breakdown Data by Type
4.1 Global Multiple Myeloma Therapy Historic Market Size by Type (2020-2025)
4.2 Global Multiple Myeloma Therapy Forecasted Market Size by Type (2026-2031)
5 Multiple Myeloma Therapy Breakdown Data by Application
5.1 Global Multiple Myeloma Therapy Historic Market Size by Application (2020-2025)
5.2 Global Multiple Myeloma Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Multiple Myeloma Therapy Market Size (2020-2031)
6.2 North America Multiple Myeloma Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Multiple Myeloma Therapy Market Size by Country (2020-2025)
6.4 North America Multiple Myeloma Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Multiple Myeloma Therapy Market Size (2020-2031)
7.2 Europe Multiple Myeloma Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Multiple Myeloma Therapy Market Size by Country (2020-2025)
7.4 Europe Multiple Myeloma Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Multiple Myeloma Therapy Market Size (2020-2031)
8.2 Asia-Pacific Multiple Myeloma Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Multiple Myeloma Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Multiple Myeloma Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Multiple Myeloma Therapy Market Size (2020-2031)
9.2 Latin America Multiple Myeloma Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Multiple Myeloma Therapy Market Size by Country (2020-2025)
9.4 Latin America Multiple Myeloma Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Multiple Myeloma Therapy Market Size (2020-2031)
10.2 Middle East & Africa Multiple Myeloma Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Multiple Myeloma Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Multiple Myeloma Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Multiple Myeloma Therapy Introduction
11.1.4 Sanofi Revenue in Multiple Myeloma Therapy Business (2020-2025)
11.1.5 Sanofi Recent Development
11.2 Celgene
11.2.1 Celgene Company Details
11.2.2 Celgene Business Overview
11.2.3 Celgene Multiple Myeloma Therapy Introduction
11.2.4 Celgene Revenue in Multiple Myeloma Therapy Business (2020-2025)
11.2.5 Celgene Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Multiple Myeloma Therapy Introduction
11.3.4 Johnson & Johnson Revenue in Multiple Myeloma Therapy Business (2020-2025)
11.3.5 Johnson & Johnson Recent Development
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Company Details
11.4.2 GlaxoSmithKline plc Business Overview
11.4.3 GlaxoSmithKline plc Multiple Myeloma Therapy Introduction
11.4.4 GlaxoSmithKline plc Revenue in Multiple Myeloma Therapy Business (2020-2025)
11.4.5 GlaxoSmithKline plc Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Multiple Myeloma Therapy Introduction
11.5.4 Roche Revenue in Multiple Myeloma Therapy Business (2020-2025)
11.5.5 Roche Recent Development
11.6 AbbVie Inc.
11.6.1 AbbVie Inc. Company Details
11.6.2 AbbVie Inc. Business Overview
11.6.3 AbbVie Inc. Multiple Myeloma Therapy Introduction
11.6.4 AbbVie Inc. Revenue in Multiple Myeloma Therapy Business (2020-2025)
11.6.5 AbbVie Inc. Recent Development
11.7 Amgen Inc.
11.7.1 Amgen Inc. Company Details
11.7.2 Amgen Inc. Business Overview
11.7.3 Amgen Inc. Multiple Myeloma Therapy Introduction
11.7.4 Amgen Inc. Revenue in Multiple Myeloma Therapy Business (2020-2025)
11.7.5 Amgen Inc. Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Details
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Multiple Myeloma Therapy Introduction
11.8.4 Novartis AG Revenue in Multiple Myeloma Therapy Business (2020-2025)
11.8.5 Novartis AG Recent Development
11.9 Millennium Pharmaceuticals
11.9.1 Millennium Pharmaceuticals Company Details
11.9.2 Millennium Pharmaceuticals Business Overview
11.9.3 Millennium Pharmaceuticals Multiple Myeloma Therapy Introduction
11.9.4 Millennium Pharmaceuticals Revenue in Multiple Myeloma Therapy Business (2020-2025)
11.9.5 Millennium Pharmaceuticals Recent Development
11.10 Innate Pharma SA
11.10.1 Innate Pharma SA Company Details
11.10.2 Innate Pharma SA Business Overview
11.10.3 Innate Pharma SA Multiple Myeloma Therapy Introduction
11.10.4 Innate Pharma SA Revenue in Multiple Myeloma Therapy Business (2020-2025)
11.10.5 Innate Pharma SA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Multiple Myeloma Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Targeted Therapy
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Radiotherapy
Table 5. Key Players of Bone Marrow Transplant
Table 6. Key Players of Others
Table 7. Global Multiple Myeloma Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Multiple Myeloma Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Multiple Myeloma Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Multiple Myeloma Therapy Market Share by Region (2020-2025)
Table 11. Global Multiple Myeloma Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Multiple Myeloma Therapy Market Share by Region (2026-2031)
Table 13. Multiple Myeloma Therapy Market Trends
Table 14. Multiple Myeloma Therapy Market Drivers
Table 15. Multiple Myeloma Therapy Market Challenges
Table 16. Multiple Myeloma Therapy Market Restraints
Table 17. Global Multiple Myeloma Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Multiple Myeloma Therapy Market Share by Players (2020-2025)
Table 19. Global Top Multiple Myeloma Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Myeloma Therapy as of 2024)
Table 20. Ranking of Global Top Multiple Myeloma Therapy Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Multiple Myeloma Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Multiple Myeloma Therapy, Headquarters and Area Served
Table 23. Global Key Players of Multiple Myeloma Therapy, Product and Application
Table 24. Global Key Players of Multiple Myeloma Therapy, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Multiple Myeloma Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Multiple Myeloma Therapy Revenue Market Share by Type (2020-2025)
Table 28. Global Multiple Myeloma Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Multiple Myeloma Therapy Revenue Market Share by Type (2026-2031)
Table 30. Global Multiple Myeloma Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Multiple Myeloma Therapy Revenue Market Share by Application (2020-2025)
Table 32. Global Multiple Myeloma Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Multiple Myeloma Therapy Revenue Market Share by Application (2026-2031)
Table 34. North America Multiple Myeloma Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Multiple Myeloma Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Multiple Myeloma Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Multiple Myeloma Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Multiple Myeloma Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Multiple Myeloma Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Multiple Myeloma Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Multiple Myeloma Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Multiple Myeloma Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Multiple Myeloma Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Multiple Myeloma Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Multiple Myeloma Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Multiple Myeloma Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Multiple Myeloma Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Multiple Myeloma Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 49. Sanofi Company Details
Table 50. Sanofi Business Overview
Table 51. Sanofi Multiple Myeloma Therapy Product
Table 52. Sanofi Revenue in Multiple Myeloma Therapy Business (2020-2025) & (US$ Million)
Table 53. Sanofi Recent Development
Table 54. Celgene Company Details
Table 55. Celgene Business Overview
Table 56. Celgene Multiple Myeloma Therapy Product
Table 57. Celgene Revenue in Multiple Myeloma Therapy Business (2020-2025) & (US$ Million)
Table 58. Celgene Recent Development
Table 59. Johnson & Johnson Company Details
Table 60. Johnson & Johnson Business Overview
Table 61. Johnson & Johnson Multiple Myeloma Therapy Product
Table 62. Johnson & Johnson Revenue in Multiple Myeloma Therapy Business (2020-2025) & (US$ Million)
Table 63. Johnson & Johnson Recent Development
Table 64. GlaxoSmithKline plc Company Details
Table 65. GlaxoSmithKline plc Business Overview
Table 66. GlaxoSmithKline plc Multiple Myeloma Therapy Product
Table 67. GlaxoSmithKline plc Revenue in Multiple Myeloma Therapy Business (2020-2025) & (US$ Million)
Table 68. GlaxoSmithKline plc Recent Development
Table 69. Roche Company Details
Table 70. Roche Business Overview
Table 71. Roche Multiple Myeloma Therapy Product
Table 72. Roche Revenue in Multiple Myeloma Therapy Business (2020-2025) & (US$ Million)
Table 73. Roche Recent Development
Table 74. AbbVie Inc. Company Details
Table 75. AbbVie Inc. Business Overview
Table 76. AbbVie Inc. Multiple Myeloma Therapy Product
Table 77. AbbVie Inc. Revenue in Multiple Myeloma Therapy Business (2020-2025) & (US$ Million)
Table 78. AbbVie Inc. Recent Development
Table 79. Amgen Inc. Company Details
Table 80. Amgen Inc. Business Overview
Table 81. Amgen Inc. Multiple Myeloma Therapy Product
Table 82. Amgen Inc. Revenue in Multiple Myeloma Therapy Business (2020-2025) & (US$ Million)
Table 83. Amgen Inc. Recent Development
Table 84. Novartis AG Company Details
Table 85. Novartis AG Business Overview
Table 86. Novartis AG Multiple Myeloma Therapy Product
Table 87. Novartis AG Revenue in Multiple Myeloma Therapy Business (2020-2025) & (US$ Million)
Table 88. Novartis AG Recent Development
Table 89. Millennium Pharmaceuticals Company Details
Table 90. Millennium Pharmaceuticals Business Overview
Table 91. Millennium Pharmaceuticals Multiple Myeloma Therapy Product
Table 92. Millennium Pharmaceuticals Revenue in Multiple Myeloma Therapy Business (2020-2025) & (US$ Million)
Table 93. Millennium Pharmaceuticals Recent Development
Table 94. Innate Pharma SA Company Details
Table 95. Innate Pharma SA Business Overview
Table 96. Innate Pharma SA Multiple Myeloma Therapy Product
Table 97. Innate Pharma SA Revenue in Multiple Myeloma Therapy Business (2020-2025) & (US$ Million)
Table 98. Innate Pharma SA Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
Table 102. Authors List of This Report
List of Figures
Figure 1. Multiple Myeloma Therapy Picture
Figure 2. Global Multiple Myeloma Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Multiple Myeloma Therapy Market Share by Type: 2024 VS 2031
Figure 4. Targeted Therapy Features
Figure 5. Chemotherapy Features
Figure 6. Radiotherapy Features
Figure 7. Bone Marrow Transplant Features
Figure 8. Others Features
Figure 9. Global Multiple Myeloma Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Multiple Myeloma Therapy Market Share by Application: 2024 VS 2031
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Multiple Myeloma Therapy Report Years Considered
Figure 14. Global Multiple Myeloma Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Multiple Myeloma Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Multiple Myeloma Therapy Market Share by Region: 2024 VS 2031
Figure 17. Global Multiple Myeloma Therapy Market Share by Players in 2024
Figure 18. Global Top Multiple Myeloma Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Myeloma Therapy as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Multiple Myeloma Therapy Revenue in 2024
Figure 20. North America Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Multiple Myeloma Therapy Market Share by Country (2020-2031)
Figure 22. United States Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Multiple Myeloma Therapy Market Share by Country (2020-2031)
Figure 26. Germany Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Multiple Myeloma Therapy Market Share by Region (2020-2031)
Figure 34. China Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Multiple Myeloma Therapy Market Share by Country (2020-2031)
Figure 42. Mexico Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Multiple Myeloma Therapy Market Share by Country (2020-2031)
Figure 46. Turkey Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Sanofi Revenue Growth Rate in Multiple Myeloma Therapy Business (2020-2025)
Figure 50. Celgene Revenue Growth Rate in Multiple Myeloma Therapy Business (2020-2025)
Figure 51. Johnson & Johnson Revenue Growth Rate in Multiple Myeloma Therapy Business (2020-2025)
Figure 52. GlaxoSmithKline plc Revenue Growth Rate in Multiple Myeloma Therapy Business (2020-2025)
Figure 53. Roche Revenue Growth Rate in Multiple Myeloma Therapy Business (2020-2025)
Figure 54. AbbVie Inc. Revenue Growth Rate in Multiple Myeloma Therapy Business (2020-2025)
Figure 55. Amgen Inc. Revenue Growth Rate in Multiple Myeloma Therapy Business (2020-2025)
Figure 56. Novartis AG Revenue Growth Rate in Multiple Myeloma Therapy Business (2020-2025)
Figure 57. Millennium Pharmaceuticals Revenue Growth Rate in Multiple Myeloma Therapy Business (2020-2025)
Figure 58. Innate Pharma SA Revenue Growth Rate in Multiple Myeloma Therapy Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Multiple Myeloma Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Targeted Therapy
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Radiotherapy
Table 5. Key Players of Bone Marrow Transplant
Table 6. Key Players of Others
Table 7. Global Multiple Myeloma Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Multiple Myeloma Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Multiple Myeloma Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Multiple Myeloma Therapy Market Share by Region (2020-2025)
Table 11. Global Multiple Myeloma Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Multiple Myeloma Therapy Market Share by Region (2026-2031)
Table 13. Multiple Myeloma Therapy Market Trends
Table 14. Multiple Myeloma Therapy Market Drivers
Table 15. Multiple Myeloma Therapy Market Challenges
Table 16. Multiple Myeloma Therapy Market Restraints
Table 17. Global Multiple Myeloma Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Multiple Myeloma Therapy Market Share by Players (2020-2025)
Table 19. Global Top Multiple Myeloma Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Myeloma Therapy as of 2024)
Table 20. Ranking of Global Top Multiple Myeloma Therapy Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Multiple Myeloma Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Multiple Myeloma Therapy, Headquarters and Area Served
Table 23. Global Key Players of Multiple Myeloma Therapy, Product and Application
Table 24. Global Key Players of Multiple Myeloma Therapy, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Multiple Myeloma Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Multiple Myeloma Therapy Revenue Market Share by Type (2020-2025)
Table 28. Global Multiple Myeloma Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Multiple Myeloma Therapy Revenue Market Share by Type (2026-2031)
Table 30. Global Multiple Myeloma Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Multiple Myeloma Therapy Revenue Market Share by Application (2020-2025)
Table 32. Global Multiple Myeloma Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Multiple Myeloma Therapy Revenue Market Share by Application (2026-2031)
Table 34. North America Multiple Myeloma Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Multiple Myeloma Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Multiple Myeloma Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Multiple Myeloma Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Multiple Myeloma Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Multiple Myeloma Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Multiple Myeloma Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Multiple Myeloma Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Multiple Myeloma Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Multiple Myeloma Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Multiple Myeloma Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Multiple Myeloma Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Multiple Myeloma Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Multiple Myeloma Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Multiple Myeloma Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 49. Sanofi Company Details
Table 50. Sanofi Business Overview
Table 51. Sanofi Multiple Myeloma Therapy Product
Table 52. Sanofi Revenue in Multiple Myeloma Therapy Business (2020-2025) & (US$ Million)
Table 53. Sanofi Recent Development
Table 54. Celgene Company Details
Table 55. Celgene Business Overview
Table 56. Celgene Multiple Myeloma Therapy Product
Table 57. Celgene Revenue in Multiple Myeloma Therapy Business (2020-2025) & (US$ Million)
Table 58. Celgene Recent Development
Table 59. Johnson & Johnson Company Details
Table 60. Johnson & Johnson Business Overview
Table 61. Johnson & Johnson Multiple Myeloma Therapy Product
Table 62. Johnson & Johnson Revenue in Multiple Myeloma Therapy Business (2020-2025) & (US$ Million)
Table 63. Johnson & Johnson Recent Development
Table 64. GlaxoSmithKline plc Company Details
Table 65. GlaxoSmithKline plc Business Overview
Table 66. GlaxoSmithKline plc Multiple Myeloma Therapy Product
Table 67. GlaxoSmithKline plc Revenue in Multiple Myeloma Therapy Business (2020-2025) & (US$ Million)
Table 68. GlaxoSmithKline plc Recent Development
Table 69. Roche Company Details
Table 70. Roche Business Overview
Table 71. Roche Multiple Myeloma Therapy Product
Table 72. Roche Revenue in Multiple Myeloma Therapy Business (2020-2025) & (US$ Million)
Table 73. Roche Recent Development
Table 74. AbbVie Inc. Company Details
Table 75. AbbVie Inc. Business Overview
Table 76. AbbVie Inc. Multiple Myeloma Therapy Product
Table 77. AbbVie Inc. Revenue in Multiple Myeloma Therapy Business (2020-2025) & (US$ Million)
Table 78. AbbVie Inc. Recent Development
Table 79. Amgen Inc. Company Details
Table 80. Amgen Inc. Business Overview
Table 81. Amgen Inc. Multiple Myeloma Therapy Product
Table 82. Amgen Inc. Revenue in Multiple Myeloma Therapy Business (2020-2025) & (US$ Million)
Table 83. Amgen Inc. Recent Development
Table 84. Novartis AG Company Details
Table 85. Novartis AG Business Overview
Table 86. Novartis AG Multiple Myeloma Therapy Product
Table 87. Novartis AG Revenue in Multiple Myeloma Therapy Business (2020-2025) & (US$ Million)
Table 88. Novartis AG Recent Development
Table 89. Millennium Pharmaceuticals Company Details
Table 90. Millennium Pharmaceuticals Business Overview
Table 91. Millennium Pharmaceuticals Multiple Myeloma Therapy Product
Table 92. Millennium Pharmaceuticals Revenue in Multiple Myeloma Therapy Business (2020-2025) & (US$ Million)
Table 93. Millennium Pharmaceuticals Recent Development
Table 94. Innate Pharma SA Company Details
Table 95. Innate Pharma SA Business Overview
Table 96. Innate Pharma SA Multiple Myeloma Therapy Product
Table 97. Innate Pharma SA Revenue in Multiple Myeloma Therapy Business (2020-2025) & (US$ Million)
Table 98. Innate Pharma SA Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
Table 102. Authors List of This Report
List of Figures
Figure 1. Multiple Myeloma Therapy Picture
Figure 2. Global Multiple Myeloma Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Multiple Myeloma Therapy Market Share by Type: 2024 VS 2031
Figure 4. Targeted Therapy Features
Figure 5. Chemotherapy Features
Figure 6. Radiotherapy Features
Figure 7. Bone Marrow Transplant Features
Figure 8. Others Features
Figure 9. Global Multiple Myeloma Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Multiple Myeloma Therapy Market Share by Application: 2024 VS 2031
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Multiple Myeloma Therapy Report Years Considered
Figure 14. Global Multiple Myeloma Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Multiple Myeloma Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Multiple Myeloma Therapy Market Share by Region: 2024 VS 2031
Figure 17. Global Multiple Myeloma Therapy Market Share by Players in 2024
Figure 18. Global Top Multiple Myeloma Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Myeloma Therapy as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Multiple Myeloma Therapy Revenue in 2024
Figure 20. North America Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Multiple Myeloma Therapy Market Share by Country (2020-2031)
Figure 22. United States Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Multiple Myeloma Therapy Market Share by Country (2020-2031)
Figure 26. Germany Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Multiple Myeloma Therapy Market Share by Region (2020-2031)
Figure 34. China Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Multiple Myeloma Therapy Market Share by Country (2020-2031)
Figure 42. Mexico Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Multiple Myeloma Therapy Market Share by Country (2020-2031)
Figure 46. Turkey Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Sanofi Revenue Growth Rate in Multiple Myeloma Therapy Business (2020-2025)
Figure 50. Celgene Revenue Growth Rate in Multiple Myeloma Therapy Business (2020-2025)
Figure 51. Johnson & Johnson Revenue Growth Rate in Multiple Myeloma Therapy Business (2020-2025)
Figure 52. GlaxoSmithKline plc Revenue Growth Rate in Multiple Myeloma Therapy Business (2020-2025)
Figure 53. Roche Revenue Growth Rate in Multiple Myeloma Therapy Business (2020-2025)
Figure 54. AbbVie Inc. Revenue Growth Rate in Multiple Myeloma Therapy Business (2020-2025)
Figure 55. Amgen Inc. Revenue Growth Rate in Multiple Myeloma Therapy Business (2020-2025)
Figure 56. Novartis AG Revenue Growth Rate in Multiple Myeloma Therapy Business (2020-2025)
Figure 57. Millennium Pharmaceuticals Revenue Growth Rate in Multiple Myeloma Therapy Business (2020-2025)
Figure 58. Innate Pharma SA Revenue Growth Rate in Multiple Myeloma Therapy Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232